Accounting for Time-Varying Confounding in the Relationship between Obesity and Coronary Heart Disease: Analysis with G-Estimation

American Journal of Epidemiology

Volumn 187, Issue 6, 2018, Pages 1319-1326

  Shakiba, Maryam ^a,b,c   Mansournia, Mohammad Ali ^d   Salari, Arsalan ^a   Soori, Hamid ^e   Mansournia, Nasrin ^f   Kaufman, Jay S ^g  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

abdominal obesity; coronary heart disease; epidemiologic methods; G estimation; general obesity; obesity; time varying confounding

Indexed keywords

ABUNDANCE ESTIMATION; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; ESTIMATION METHOD; HEALTH RISK; METABOLISM; OBESITY;

ABDOMINAL OBESITY; ACCELERATED FAILURE-TIME MODEL; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; G-ESTIMATION; HAZARD RATIO; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLISM; MIDDLE AGED; OBESITY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS; UNITED STATES; WAIST CIRCUMFERENCE; WAIST HIP RATIO; COMPLICATION; CORONARY ARTERY DISEASE; PROSPECTIVE STUDY;

UNITED STATES;

CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; OBESITY, ABDOMINAL; PROSPECTIVE STUDIES;

EID: 85047992302     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwx360     Document Type: Article

References (55)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128.
2. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197-2223.
3. Canoy D, Boekholdt SM, Wareham N, et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007;116(25):2933-2943.
4. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care. 1999;22(11):1808-1812.
5. Litwin SE. Which measures of obesity best predict cardiovascular risk? J Am Coll Cardiol. 2008;52(8):616-619.
6. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord. 2001;25(7):1047-1056.
7. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998; 280(21):1843-1848.
8. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995; 141(12):1117-1127.
9. Terry RB, Page WF, Haskell WL. Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a twenty-three year follow-up study. Int J Obes Relat Metab Disord. 1992;16(6):417-423.
10. de Koning L, Merchant AT, Pogue J, et al. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28(7):850-856.
11. Lakka HM, Lakka TA, Tuomilehto J, et al. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23(9):706-713.
12. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMIMediated Effects), Lu Y, Hajifathalian K, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014; 383(9921):970-983.
13. Yatsuya H, Toyoshima H, Yamagishi K, et al. Body mass index and risk of stroke and myocardial infarction in a relatively lean population: meta-analysis of 16 Japanese cohorts using individual data. Circ Cardiovasc Qual Outcomes. 2010;3(5):498-505.
14. Robins J. A new approach to causal inference in mortality studies with a sustained exposure period-application to control of the healthy worker survivor effect. Math Model. 1986;7(9-12):1393-1512.
15. Robins J, Hernán M. Estimation of the causal effects of timevarying exposures. In: Fitzmaurice GM, Davidian M, Verbeke G, et al., eds. Longitudinal Data Analysis. New York, NY: Chapman and Hall/CRC Press; 2009:553-599.
16. Robins JM, Blevins D, Ritter G, et al. G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology. 1992;3(4):319-336.
17. Mansournia MA, Etminan M, Danaei G, et al. Handling time varying confounding in observational research. BMJ. 2017; 359:j4587.
18. HernánMA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5):615-625.
19. Mansournia MA, Danaei G, Forouzanfar MH, et al. Effect of physical activity on functional performance and knee pain in patients with osteoarthritis: analysis with marginal structural models. Epidemiology. 2012;23(4):631-640.
20. Robins J. The control of confounding by intermediate variables. Stat Med. 1989;8(6):679-701.
21. Witteman JC, D'Agostino RB, Stijnen T, et al. G-estimation of causal effects: isolated systolic hypertension and cardiovascular death in the Framingham Heart Study. Am J Epidemiol. 1998;148(4):390-401.
22. Robins JM. Structural nested failure timemodels. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Chichester, United Kingdom: John Wiley&Sons Ltd.; 1997:4372-4389.
23. Sterne JAC, Tilling K. G-estimation of causal effects, allowing for time-varying confounding. Stata J. 2002;2(2): 164-182.
24. Chevrier J, Picciotto S, Eisen EA. A comparison of standard methods with g-estimation of accelerated failure-time models to address the healthy-worker survivor effect: application in a cohort of autoworkers exposed to metalworking fluids. Epidemiology. 2012;23(2):212-219.
25. Costello S, Picciotto S, Rehkopf DH, et al. Social disparities in heart disease risk and survivor bias among autoworkers: an examination based on survival models and g-estimation. Occup Environ Med. 2015;72(2):138-144.
26. Hernán MA, Cole SR, Margolick J, et al. Structural accelerated failure time models for survival analysis in studies with timevarying treatments. Pharmacoepidemiol Drug Saf. 2005;14(7): 477-491.
27. Keiding N, Filiberti M, Esbjerg S, et al. The graft versus leukemia effect after bone marrow transplantation: a case study using structural nested failure time models. Biometrics. 1999; 55(1):23-28.
28. Joffe MM, Hoover DR, Jacobson LP, et al. Estimating the effect of zidovudine on Kaposi's sarcoma from observational data using a rank preserving structural failure-time model. Stat Med. 1998;17(10):1073-1102.
29. Tilling K, Sterne JA, Szklo M. Estimating the effect of cardiovascular risk factors on all-cause mortality and incidence of coronary heart disease using G-estimation: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2002;155(8):710-718.
30. The ARIC Investigators. The Atherosclerosis Risk in Communities Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
31. World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8-11 December 2008. Geneva, Switzerland: World Health Organization; 2011.
32. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation. 2002;106(25): 3143-3421.
33. Greenland S, Mansournia MA. Limitations of individual causal models, causal graphs, and ignorability assumptions, as illustrated by random confounding and design unfaithfulness. Eur J Epidemiol. 2015;30(10):1101-1110.
34. Mansournia MA, Hernán MA, Greenland S. Matched designs and causal diagrams. Int J Epidemiol. 2013;42(3):860-869.
35. Mansournia MA, Higgins JP, Sterne JA, et al. Biases in randomized trials: a conversation between trialists and epidemiologists. Epidemiology. 2017;28(1):54-59.
36. Joffe MM, Hoover DR, Jacobson LP, et al. Effect of treatment with zidovudine on subsequent incidence of Kaposi's sarcoma. Clin Infect Dis. 1997;25(5):1125-1133.
37. Naimi AI, Cole SR, Kennedy EH. An introduction to g methods. Int J Epidemiol. 2017;46(2):756-762.
38. Mansournia MA, Altman DG. Inverse probability weighting. BMJ. 2016;352:i189.
39. Danaei G, Robins JM, Young JG, et al. Weight loss and coronary heart disease: sensitivity analysis for unmeasured confounding by undiagnosed disease. Epidemiology. 2016; 27(2):302-310.
40. Hagg S, Fall T, Ploner A, et al. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol. 2015;44(2):578-586.
41. Holmes MV, Lange LA, Palmer T, et al. Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis. Am J Hum Genet. 2014;94(2): 198-208.
42. Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35(12):2613-2617.
43. Look AHEAD Research Group, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl JMed. 2013;369(2):145-154.
44. Cameron AJ, Zimmet PZ. Expanding evidence for the multiple dangers of epidemic abdominal obesity. Circulation. 2008; 117(13):1624-1626.
45. Canoy D, Wareham N, Luben R, et al. Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: results from the EPIC-Norfolk population-based cohort study. Atherosclerosis. 2006;189(2):420-427.
46. Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003;254(6):555-563.
47. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379-384.
48. Keihani S, Hosseinpanah F, Barzin M, et al. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study. Atherosclerosis. 2015;238(2):256-263.
49. Logue J, Murray HM, Welsh P, et al. Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation. Heart. 2011;97(7):564-568.
50. Page JH, Rexrode KM, Hu F, et al. Waist-height ratio as a predictor of coronary heart disease among women. Epidemiology. 2009;20(3):361-366.
51. Mohammad K, Hashemi-Nazari SS, Mansournia N, et al. Marginal versus conditional causal effects. J Biostat Epidemiol. 2015;1(3-4):121-128.
52. Mansournia MA, Greenland S. The relation of collapsibility and confounding to faithfulness and stability. Epidemiology. 2015;26(4):466-472.
53. Hernán MA, Robins JM. Causal Inference. Boca Raton, FL: Chapman&Hall/CRC; 2017.
54. Hernán MA. Invited commentary: hypothetical interventions to define causal effects-afterthought or prerequisite? Am J Epidemiol. 2005;162(7):618-620.
55. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes (Lond). 2008;32(suppl 3):S8-S14.